Sanguine is a brand that specializes in biospecimen collection, offering a wide range of products and services to both patients and researchers. With a mobile approach, Sanguine makes it easier for patients to get involved in medical research, providing access to hard-to-reach populations. Patients can conveniently participate from the comfort of their own homes, supported by on-call study coordinators and ensuring full privacy and information security.

Sanguine also offers monetary compensation and comes recommended by leading patient advocacy groups. For researchers, Sanguine offers a patient-centric approach to biospecimen collection, allowing access to impossible samples and facilitating better patient retention. They provide minimally-invasive biospecimens, questionnaire-based studies, and multiple data points per sample, resulting in improved translational insights.

With over 600 unique studies, a patient community of 50,000+, and expertise in various research areas including autoimmune, neurodegenerative, and hematologic diseases, Sanguine is committed to bridging the gap between patients and researchers. Their mission is to accelerate translational biomedical research by removing barriers to patient participation and ensuring a better patient experience